Table 4. Subgroup analyses of tumor antigens on OS and DFS in CEA-high CRC patients.
OS | DFS | |||||||
---|---|---|---|---|---|---|---|---|
Univariate analysis | P | Multivariate analysis | P | Univariate analysis | P | Multivariate analysis | P | |
HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | |||||
Age (years) | 0.235 | 0.452 | ||||||
≤60 | 1.000 | 1.000 | ||||||
>60 | 1.303 (0.841–2.019) | 1.147 (0.803–1.639) | ||||||
Gender | 0.060 | 0.248 | ||||||
Male | 1.000 | 1.000 | ||||||
Female | 1.670 (0.978–2.851) | 1.265 (0.849–1.887) | ||||||
Tumor location | 0.077 | 0.012 | 0.405 | |||||
Colon | 1.000 | 1.000 | 1.000 | |||||
Rectum | 0.676 (0.438–1.043) | 0.636 (0.446–0.907) | 0.807 (0.486–1.338) | |||||
Tumor length (cm) | 0.503 | 0.747 | ||||||
≤3 cm | 1.000 | 1.000 | ||||||
>3 cm | 1.188 (0.718–1.965) | 1.069 (0.714–1.599) | ||||||
T stage | 0.001 | 0.004 | <0.001 | 0.063 | ||||
T1 | 1.000 | 1.000 | 1.000 | 1.000 | ||||
T2 | 0.670 (0.075–6.001) | 1.063 (0.113–9.978) | 1.360 (0.167–11.056) | 1.371 (0.166–11.314) | ||||
T3 | 0.892 (0.122–6.534) | 0.553 (0.072–4.263) | 1.570 (0.217–11.365) | 0.871 (0.117–6.479) | ||||
T4 | 2.066 (0.284–15.004) | 1.320 (0.172–10.111) | 3.598 (0.499–25.941) | 1.727 (0.220–13.525) | ||||
N stage | <0.001 | 0.001 | <0.001 | 0.002 | ||||
N0 | 1.000 | 1.000 | 1.000 | 1.000 | ||||
N1 | 2.954 (1.645–5.303) | 2.497 (1.334–4.675) | 1.765 (1.122–2.777) | 1.360 (0.822–2.250) | ||||
N2 | 4.550 (2.573–8.048) | 1.566(1.817–7.051) | 3.150 (2.049–4.842) | 2.566 (1.482–4.444) | ||||
Differentiation | 0.118 | 0.008 | 0.878 | |||||
Well/Moderate | 1.000 | 1.000 | 1.000 | |||||
Poor | 1.625 (1.025–2.575) | 1.797 (1.235–2.615) | 1.095 (0.730–1.643) | |||||
Unknown | 1.273 (0.395–4.101) | 1.555 (0.569–4.250) | 0.914 (0.321–2.599) | |||||
Venous invasion | <0.001 | <0.001 | <0.001 | 0.484 | ||||
Negative | 1.000 | 1.000 | 1.000 | 1.000 | ||||
Positive | 2.940 (1.906–4.534) | 3.013 (2.090–4.344) | 2.772 (1.943–3.953) | 1.185 (0.736–1.907) | ||||
Perineural invasion | <0.001 | <0.001 | <0.001 | 0.038 | ||||
Negative | 1.000 | 1.000 | 1.000 | 1.000 | ||||
Positive | 2.285 (1.480–3.528) | 2.019 (1.388–2.936) | 2.142 (1.492–3.076) | 1.530 (1.023–2.289) | ||||
CA199 (U/mL) | 0.001 | 0.775 | 0.084 | |||||
Normal (0–27) | 1.000 | 1.000 | 1.000 | |||||
High (>27) | 2.102 (1.361–3.247) | 1.094 (0.592–2.019) | 1.367 (0.959–1.949) | |||||
CA50 (IU/mL) | <0.001 | 0.078 | <0.001 | 0.118 | ||||
Normal (0–25) | 1.000 | 1.000 | 1.000 | 1.000 | ||||
High (>25) | 3.063 (1.919–4.887) | 1.673 (0.944–2.963) | 2.182 (1.441–3.303) | 1.429 (0.913–2.236) | ||||
CA125 (U/mL) | 0.292 | 0.122 | <0.001 | 0.158 | ||||
Normal (0–35) | 1.000 | 1.000 | 1.000 | 1.000 | ||||
High (>35) | 3.085 (1.808–5.266) | 1.639 (0.877–3.065) | 2.367 (1.463–3.828) | 1.466 (0.862–2.492) | ||||
CA242 | 0.003 | 0.538 | 0.095 | |||||
Normal (0–25) | 1.000 | 1.000 | 1.000 | |||||
High (>35) | 1.964 (1.268–3.042) | 1.201 (0.671–2.149) | 1.352 (0.949–1.925) | |||||
CA724 (U/mL) | <0.001 | <0.001 | <0.001 | 0.001 | ||||
Normal (0–20) | 1.000 | 1.000 | 1.000 | 1.000 | ||||
High (>20) | 3.096 (2.009–4.772) | 2.853 (1.769–4.603) | 2.166 (1.506–3.114) | 2.059 (1.360–3.117) |